D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 44 Citations 7,108 105 World Ranking 3240 National Ranking 31

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

His primary scientific interests are in Immunology, SuPAR, Internal medicine, Tuberculosis and Antigen. His Immunology study combines topics from a wide range of disciplines, such as Plasminogen activator, Proportional hazards model, Disease and Cohort. His SuPAR research incorporates themes from Inflammation, C-reactive protein, Cancer and Prospective cohort study.

Internal medicine is often connected to Gastroenterology in his work. In his research, Pathology, T cell, Biomarker and Latent tuberculosis is intimately related to Whole blood, which falls under the overarching field of Tuberculosis. He combines subjects such as Survival analysis and Interferon gamma with his study of Antigen.

His most cited work include:

  • suPAR: the molecular crystal ball. (281 citations)
  • Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data (278 citations)
  • Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. (249 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are SuPAR, Internal medicine, Immunology, Biomarker and Inflammation. Jesper Eugen-Olsen interconnects Cancer and Disease in the investigation of issues within SuPAR. His biological study spans a wide range of topics, including Gastroenterology and Endocrinology.

Immunology is closely attributed to Tuberculosis in his research. His research integrates issues of Prospective cohort study and Intensive care medicine in his study of Biomarker. His work in Viral disease addresses issues such as Acquired immunodeficiency syndrome, which are connected to fields such as Genotype.

He most often published in these fields:

  • SuPAR (56.50%)
  • Internal medicine (48.88%)
  • Immunology (36.77%)

What were the highlights of his more recent work (between 2018-2021)?

  • SuPAR (56.50%)
  • Internal medicine (48.88%)
  • Biomarker (15.25%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in SuPAR, Internal medicine, Biomarker, Hazard ratio and Anakinra. His studies in SuPAR integrate themes in fields like Inflammation, Interquartile range and Respiratory failure. His Internal medicine study frequently draws connections to adjacent fields such as Gastroenterology.

His Biomarker research is multidisciplinary, incorporating perspectives in Endocrinology and Blood pressure. His Coronavirus disease 2019 study which covers Symptom onset that intersects with Immunology. His Immunology study integrates concerns from other disciplines, such as Plasma samples and Polymerase chain reaction.

Between 2018 and 2021, his most popular works were:

  • Association of Adverse Experiences and Exposure to Violence in Childhood and Adolescence With Inflammatory Burden in Young People (39 citations)
  • Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. (36 citations)
  • Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood (29 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

The scientist’s investigation covers issues in SuPAR, Internal medicine, Biomarker, Hazard ratio and Urokinase Plasminogen Activator. His SuPAR study necessitates a more in-depth grasp of Receptor. His Internal medicine study frequently involves adjacent topics like Diabetes mellitus.

His studies deal with areas such as Clinical nutrition, Proportional hazards model, Risk of mortality and Population study as well as Hazard ratio. His Urokinase Plasminogen Activator research incorporates elements of Immunology, Respiratory failure, Betacoronavirus and Pneumonia. His work carried out in the field of Body mass index brings together such families of science as Young adult, Cohort study and C-reactive protein.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

suPAR: the molecular crystal ball.

Maria Thunø;Betina Macho;Jesper Eugen-Olsen.
Disease Markers (2009)

431 Citations

Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data

J. P.A. Ioannidis;P. S. Rosenberg;J. J. Goedert;L. J. Ashton.
Annals of Internal Medicine (2001)

367 Citations

Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.

Kristian Kofoed;Ove Andersen;Gitte Kronborg;Michael Tvede.
Critical Care (2007)

348 Citations

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.

J. Eugen‐Olsen;O. Andersen;A. Linneberg;S. Ladelund.
Journal of Internal Medicine (2010)

314 Citations

Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia

Jannik Helweg-Larsen;Thomas L Benfield;Jesper Eugen-Olsen;Jens D Lundgren.
The Lancet (1999)

298 Citations

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.

Jesper Eugen-Olsen;Astrid K.N. Iversen;Peter Garred;Uffe Koppelhus.
AIDS (1997)

276 Citations

Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.

Nicolai Sidenius;Cornelis F. M. Sier;Henrik Ullum;Bente Klarlund Pedersen.
Blood (2000)

235 Citations

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.

Troels K. H. Scheel;Judith M. Gottwein;Tanja B. Jensen;Jannick C. Prentoe.
Proceedings of the National Academy of Sciences of the United States of America (2008)

213 Citations

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

M. Ruhwald;T. Bodmer;C. Maier;M. Jepsen.
European Respiratory Journal (2008)

212 Citations

Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.

L Andresen;V L Jørgensen;A Perner;A Hansen.
Gut (2005)

194 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jesper Eugen-Olsen

Jens Bukh

Jens Bukh

University of Copenhagen

Publications: 83

Laurence Huang

Laurence Huang

University of California, San Francisco

Publications: 27

Gerhard Walzl

Gerhard Walzl

Stellenbosch University

Publications: 20

Hanneke Schuitemaker

Hanneke Schuitemaker

Janssen (Belgium)

Publications: 20

Peter Aaby

Peter Aaby

Bandim Health Project, Denmark

Publications: 19

Mette M. Rosenkilde

Mette M. Rosenkilde

University of Copenhagen

Publications: 19

Steven R. Meshnick

Steven R. Meshnick

University of North Carolina at Chapel Hill

Publications: 18

Delia Goletti

Delia Goletti

Istituto Sperimentale Italiano Lazzaro Spallanzani

Publications: 18

John P. A. Ioannidis

John P. A. Ioannidis

Stanford University

Publications: 18

Guido Poli

Guido Poli

Vita-Salute San Raffaele University

Publications: 17

Peter W. Hunt

Peter W. Hunt

University of California, San Francisco

Publications: 16

Robert F. Miller

Robert F. Miller

University College London

Publications: 16

Tom H. M. Ottenhoff

Tom H. M. Ottenhoff

Leiden University Medical Center

Publications: 16

Peter E. Nielsen

Peter E. Nielsen

University of Copenhagen

Publications: 15

Stephen J. O'Brien

Stephen J. O'Brien

ITMO University

Publications: 15

Henrik Ullum

Henrik Ullum

Statens Serum Institut

Publications: 14

Trending Scientists

Clint Dawson

Clint Dawson

The University of Texas at Austin

Michael F. Angelo

Michael F. Angelo

Hewlett-Packard (United States)

Charles J. O'Connor

Charles J. O'Connor

University of New Orleans

Cinzia Chiappe

Cinzia Chiappe

University of Pisa

Fei Li

Fei Li

Xi'an Jiaotong University

John W. Freeland

John W. Freeland

Argonne National Laboratory

Timothy L. Friesen

Timothy L. Friesen

North Dakota State University

Ralph E. Harbach

Ralph E. Harbach

American Museum of Natural History

Randall B. Boone

Randall B. Boone

Colorado State University

Andreas Faissner

Andreas Faissner

Ruhr University Bochum

Jiri Palek

Jiri Palek

Tufts University

Kenneth L. Tanaka

Kenneth L. Tanaka

United States Geological Survey

Donald S. Cherry

Donald S. Cherry

Virginia Tech

Katsumi Hirose

Katsumi Hirose

Sophia University

Tristram O. West

Tristram O. West

University of Maryland, College Park

William E. Garrett

William E. Garrett

Duke University

Something went wrong. Please try again later.